Posted on 11/2/16
Xenetic Biosciences Announces Nasdaq Listing of its Common Stock and Pricing of $10M Public Offering
LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (OTCQB: XBIO), a clinical-stage biopharmaceutical company focused on discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics, . . .
Posted on 11/1/16
Selecta Biosciences Collaborators at the NCI Present Preclinical Data Showing SVP-Rapamycin Application to Cancer Therapy
WATERTOWN, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc.(NASDAQ:SELB), a clinical-stage biopharmaceutical company developing a novel class of targeted antigen-specific immune therapies, today announced . . .
Posted on 11/1/16
3 Healthcare Stocks Warren Buffett Really Likes
What does Warren Buffett like? Playing bridge ranks pretty high on the list. University of Nebraska football does, too. Investing makes the cut, for sure. And . . .
Posted on 11/1/16
NanoViricides Signs Agreement with SUNY Upstate Medical Center
NanoViricides, Inc. (NYSE MKT: NNVC announced today that it has entered into an agreement with SUNY Upstate Medical University for the testing of its nanoviricides® drug . . .
Posted on 10/31/16
Spring Bank Pharmaceuticals Provides Corporate Update
HOPKINTON, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, . . .
Posted on 10/31/16
Here's Why Biogen Should Buy Ionis Pharmaceuticals
Despite the uncertainly created by the forthcoming retirement of Biogen's(NASDAQ:BIIB)longtime CEO, George Scangos, the biotech is reportedly continuing to hunt for deals that would diversify its . . .
Posted on 10/31/16
Will This Trend Cost Biotech Stock Investors Lots of Money?
A new approach for how payers reimburse for drugs is gaining traction. Merck (NYSE:MRK)became the latest to jump on board. The drugmaker forged a pay-for-performance deal . . .
Posted on 10/30/16
Concert Pharmaceuticals Presents Poster at 2016 North American Cystic Fibrosis Conference
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented a poster describing Phase 1 food effect and multiple ascending dose results of CTP-656 at the . . .
Posted on 10/28/16
Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results
CAMBRIDGE, Mass. and EXTON, Pa., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization . . .
Posted on 10/28/16
PAREXEL International Corporation's Q1 Report Flops, Shares Sink As Much As 13%
IMAGE SOURCE: GETTY IMAGES.What happenedShares of PAREXEL International Corporation (NASDAQ:PRXL), a biopharmaceutical services company that provides clinical research, logistics, and medical communications consulting, sank as much . . .
Posted on 10/28/16
Biogen Inc. Working With What It's Got as It Looks to Diversify
IMAGE SOURCE: GETTY IMAGES.Given the dampening U.S. market for multiple sclerosis drugs -- Biogen's (NASDAQ:BIIB)bread and butter -- the biotech's third-quarter earnings release on Wednesday was . . .
Posted on 10/28/16
Boehringer Ingelheim Named One of Science Magazine's Top Employers for the Twelfth Consecutive Year
Boehringer Ingelheim announced today that it has been named a top employer in the pharmaceutical and biotechnology industry by Science magazine. The Company was listed among . . .
Posted on 10/27/16
MetaStat Closes Private Placement of Common Stock and Warrants
BOSTON--(BUSINESS WIRE)--MetaStat, Inc. (OTCQB: MTST), a biotechnology company focused on the development and commercialization of diagnostic tests prognostic for risk of cancer metastasis, companion diagnostics to . . .
Posted on 10/27/16
Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage biotechnology company pioneering messenger RNA (mRNA) Therapeutics™ to create a new generation of transformative medicines for patients, today announced . . .
Posted on 10/27/16
Merritt Healthcare Announces M&A Advisory Firm
RIDGEFIELD, Conn., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Ambulatory surgery center (ASC) management company Merritt Healthcare is pleased to announce the spinoff of Merritt Healthcare Advisors, . . .
Posted on 10/27/16
Biogen (BIIB) Q3 2016 Results - Earnings Call Transcript
Biogen, Inc. (NASDAQ:BIIB)Q3 2016 Earnings CallOctober 26, 2016 8:30 am ETExecutivesMatthew Calistri - Biogen, Inc.George A. Scangos - Biogen, Inc.Michael D. Ehlers - Biogen, Inc.Michel Vounatsos . . .
Posted on 10/27/16
Boston Scientific (BSX) Q3 2016 Results - Earnings Call Transcript
Boston Scientific Corp. (NYSE:BSX)Q3 2016 Earnings CallOctober 26, 2016 8:00 am ETExecutivesSusan Vissers Lisa - Boston Scientific Corp.Michael F. Mahoney - Boston Scientific Corp.Daniel J. Brennan . . .
Posted on 10/27/16
Cigna, Cigna Foundation and Cordani Foundation Partner
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna (NYSE: CI) is revving up its community health and wellness efforts and announced today it will sponsor a cross-country Go. Know. Take Control. . . .
Posted on 10/27/16
Planet Fitness Announces Third Quarter 2016 Results
Planet Fitness, Inc. (NYSE: PLNT) today reported financial results for its third quarter ended September 30, 2016 and announced it is pursuing an increase in the . . .
Posted on 10/27/16
Biogen Reports Record Third Quarter 2016 Revenues of $3.0 Billion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported third quarter 2016 financial results, including: Total revenues of $3.0 billion, a 6% increase versus the same quarter . . .
Posted on 10/27/16
Ra Pharmaceuticals Prices IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focusing on using its proprietary peptide chemistry platform to develop novel therapeutics for the treatment of . . .
Posted on 10/26/16
Acella Construction Corp. Completes South Boston Animal Hospital Construction
Acella Construction Corporation, a leader in construction management for educational, medical and not-for-profit organizations in Boston
Posted on 10/26/16
Verrill Dana Recognized as One of the Best Healthcare Focused M&A Practices in U.S.
Verrill Dana has been recognized for having one of the best healthcare focused merger & acquisition practices in the U.S. by Acquisition International Magazine in its . . .
Posted on 10/26/16
Local, State Officials Congratulate Peak Physical Therapy on Opening Newest Clinic
Eric Edelman (second from left), owner of Peak Physical Therapy, prepares to cut the ribbon in celebration of the opening of Peak Physical Therapy’s newest location, . . .
Posted on 10/26/16
Collegium Prices $80 million Stock Offering
CANTON, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the pricing of its previously announced public offering of 5,000,000 shares of . . .
Boston
